|View printer-friendly version|
|Tyco Healthcare Announces Investor Meeting for Covidien Debut on New York Stock Exchange|
Tyco Healthcare will become Covidien (NYSE: COV, BSX: COV) and will begin independent trading on the New York and Bermuda Stock Exchanges on July 2, 2007, marking its debut as an independent diversified global healthcare products company.
The investor meeting will include presentations from Edward Breen, Chairman and CEO of Tyco International; Thomas Lynch, CEO of Tyco Electronics; Richard Meelia, President and CEO of Tyco Healthcare (Covidien); and select members of their management teams. Members of the media are invited to attend. The presentation on Covidien will begin at 2 p.m., followed by a question and answer session.
TYCO INVESTOR MEETING Tuesday, June 19, 2007 8 a.m. -- 4 p.m. Equitable Center Auditorium 787 Seventh Avenue (between 51st and 52nd Streets) New York City
Tyco will be providing a media room which will be located in the Equitable Center. The media room will carry a closed-circuit telecast of the meeting and will be equipped with high-speed internet connections and telephones. The press room will open at 7:30 a.m. and light refreshments will be available.
Individuals who are unable to attend the meeting in person will be able to participate in a live webcast via Tyco's corporate website www.tyco.com.
Please confirm your attendance with David T. Young, 508-261-6330 or firstname.lastname@example.org
Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien manufactures, distributes and services a diverse range of industry-leading product lines, including surgical devices, energy-based devices, respiratory and monitoring solutions, pharmaceutical products, imaging solutions, patient care and safety products, and medical supplies. With 2006 revenue of nearly $10 billion, Covidien has more than 43,000 employees worldwide in 57 countries, and its products are sold in over 130 countries. Please visit www.covidien.com to learn more about our business.
SOURCE Tyco Healthcare
Eric Kraus, Senior Vice President, Corporate Communications, +1-508-261-8305, email@example.com; or Cole Lannum, Vice President, Investor Relations, +1-508-452-4343, firstname.lastname@example.org; or Bruce Farmer, Director, Financial Communications, +1-508-452-4372, email@example.com; or Wayde McMillan, Director, Investor Relations, +1-508-452-4387, firstname.lastname@example.org, all of Tyco Healthcare